North America Life Science Tools Market Size, Share & Trends Analysis Report By End-use, By Technology (Cell Biology, Proteomics Technologies), By Product (PCR & qPCR, Cell Biology), And Segment Forecasts, 2020 - 2027

North America Life Science Tools Market Size, Share & Trends Analysis Report By End-use, By Technology (Cell Biology, Proteomics Technologies), By Product (PCR & qPCR, Cell Biology), And Segment Forecasts, 2020 - 2027

North America Life Science Tools Market Growth & Trends

The North America life science tools market size is expected to reach USD 81.9 billion by 2027 registering a CAGR of 11.6%, according to a new report by Grand View Research, Inc. The market growth is attributed to a rise in government funding for life science technologies, growth of cell & gene therapies, increasing demand for biopharmaceuticals, and a rise in competition among prominent market entities.

Competitive dynamics continue to drive a rapid pace of innovation in sequencing, multiplex platforms, and major categories of mass spectrometry and liquid chromatography; this supports growth via upgrade/replacement cycles and expands the applicability of technologies. An increase in investments for R&D of life science tools is expected to drive the market significantly.

For instance, Thermofisher Scientific, one of the leading players in the market, increased its R&D expenditure by 7.32% to USD 0.264 billion year-over-year by the quarter ending June 30, 2020. A rise in the number of strategic deals & developments coupled with the steady commercial success of biopharmaceuticals is expected to accelerate market growth over the forecast period.

The Bristol-Myers Squibb/Celgene acquisition (USD 74 billion), AbbVie/Allergan acquisition (USD 63 billion), Takeda/Shire acquisition (USD 58.6 billion), Danaher and GE Biopharma M&A deal (USD 21.4 billion), Amgen / Celgene’s Otezla deal (USD 13.4 billion), and Pfizer/Array Biopharma merger (USD 11.4 billion) were some of the largest biopharma merger and acquisition deals of 2019.

North America Life Science Tools Market Report Highlights

  • Cell biology technology dominated the market in 2019 owing to critical attention from key market players and academic institutions
  • Continuous advancements in technologies required for analysis of cells, such as cytometry, high content analysis, and microscopy, have a great impact on the growth of cancer research, stem cell research, drug discovery, and immunology
  • Moreover, these advancements have brought about high-throughput, label-free, multiplexing capabilities to cellular analysis
  • Proteomics technology is anticipated to grow at the fastest CAGR from 2020 to 2027 as proteome analysis provides a complete interpretation of structural and functional information of a cell
  • This, in turn, helps in the analysis of a cell’s response mechanism against a variety of foreign factors, including drugs
  • PCR & qPCR is estimated to register the fastest growth rate from 2020 to 2027 owing to the upsurge in PCR adoption for Covid-19 diagnosis
  • The comprehensive portfolio of cell culture media, advanced surfaces, and vessels displayed by operational entities is a result of an increase in demand for cell culture consumables among research professionals operating in the life science industry
  • The rise in the adoption of genomic and proteomic workflows in hospitals to diagnose and treat several clinical abnormalities is attributed to the largest share of the healthcare end-use segment in 2019
  • The U.S. market is expected to grow at a lucrative rate owing to an increase in the adoption of genomic medicines, biopharmaceuticals, and novel technologies for the diagnosis and treatment of clinical disorders
  • Thermo Fisher Scientific is one of the largest suppliers of a wide range of innovative solutions for the life science community


Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


Chapter 1 Methodology and Scope
1.1 Research Assumptions
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Sample size for the study on North America Life Science Tools market:
1.3.1.1 Primary Sources
1.3.1.1.1 Details of Primary Research
1.3.1.2 Secondary Data Sources
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Market Model
1.6.1 Nucleic Acid Preparation market
1.6.2 Cell biology market
1.6.2.1 Comparison of 3D cell culture techniques
1.6.3 Next - Generation Sequencing & Transfection Electroporation market
1.6.4 Market study, by Technology
1.6.5 QFD modeling for market share assessment of technologies
1.6.6 Market study, by end use
1.7 Global Market: CAGR Calculation
1.8 Objectives
1.8.1 Objective 1
1.8.2 Objective 2
Chapter 2 Executive Summary
2.1 Market Summary, 2019
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Dynamics
3.1.1 Market driver analysis
3.1.1.1 Increased government funding for life science technologies
3.1.1.2 Growth of cell and gene therapies
3.1.1.3 Rise in demand for biopharmaceuticals (biologics and biosimilars)
3.1.1.4 Technological advancements in life science tools
3.1.1.5 Applications of genomic and proteomic technologies for precision medicine
3.1.2 Market restraint analysis
3.1.2.1 High cost for some technologies
3.1.2.2 Dearth of skilled professionals
3.1.3 Market opportunity analysis
3.1.3.1 Rise in the number of strategic deals & developments
3.2 Penetration and Growth Prospect Mapping for Technology, 2019 (USD Million)
3.3 Impact of COVID - 19 pandemic on North America Life Science Tools Market
3.3.1 Impact on the supply chain
3.3.2 Impact on life sciences & healthcare industry
3.4 Market Share Analysis
3.4.1 Company Size
3.4.2 Product portfolio
3.4.3 Strategic Initiatives
3.5 Business Environment Analysis
3.5.1 SWOT Analysis; By factor (Political & Legal, Economic, and Technological)
3.5.2 Porter’s Five Forces Analysis
Chapter 4 Technology Movement Analysis
4.1 Market: Technology Movement Analysis
4.2 Genomic Technology
4.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
4.3 Proteomics Technology
4.3.1 Market estimates and forecast, 2016 - 2027 (USD Million)
4.4 Cell Biology Technology
4.4.1 Market estimates and forecast, 2016 - 2027 (USD Million)
4.5 Other Analytical & Sample Preparation Technology
4.5.1 Market estimates and forecast, 2016 - 2027 (USD Million)
4.6 Lab Supplies & Technologies
4.6.1 Market estimates and forecast, 2016 - 2027 (USD Million)
Chapter 5 Product Business Analysis
5.1 North America Life Science Tools Market: Product Movement Analysis
5.2 Next - Generation Sequencing
5.2.1 Market estimates and forecast for NGS, 2016 - 2027 (USD Million)
5.2.2 Instruments
5.2.3 Consumables
5.2.4 Services
5.3 PCR & qPCR
5.3.1 Market estimates and forecast for PCR & qPCR, 2016 - 2027 (USD Million)
5.3.2 Instruments
5.3.3 Consumables
5.3.4 Services
5.4 Flow Cytometry
5.4.1 Market for flow cytometry, 2016 - 2027 (USD Million)
5.4.2 Instruments
5.4.3 Consumables
5.4.4 Services
5.5 Nuclear Magnetic Resonance Spectroscopy (NMR)
5.5.1 Market for Nuclear magnetic resonance spectroscopy, 2016 - 2027 (USD Million)
5.5.2 Instruments
5.5.3 Consumables
5.5.4 Services
5.6 Microscopy & Electron Microscopy
5.6.1 Market for microscopy & electron microscopy, 2016 - 2027 (USD Million)
5.6.2 Instruments
5.6.3 Consumables
5.6.4 Services
5.7 Liquid Chromatography (LC)
5.7.1 Market for liquid chromatography, 2016 - 2027 (USD Million)
5.7.2 Instruments
5.7.3 Consumables
5.7.4 Services
5.8 Mass Spectrometry (MS)
5.8.1 Market for mass spectrometry, 2016 - 2027 (USD Million)
5.8.2 Instruments
5.8.3 Consumables
5.8.4 Services
5.9 Nucleic Acid Preparation (NAP)
5.9.1 Market for nucleic acid preparation, 2016 - 2027 (USD Million)
5.9.2 Instruments
5.9.3 Consumables
5.9.4 Services
5.10 Transfection Electroporation
5.10.1 Market for transfection electroporation, 2016 - 2027 (USD Million)
5.10.2 Equipment
5.10.3 Reagents
5.11 Cell Biology
5.11.1 Market for cell biology, 2016 - 2027 (USD Million)
5.11.2 Instruments
5.11.2.1 Glassware
5.11.2.2 Culture ware
5.11.2.3 Others
5.11.3 Consumables
5.11.3.1 Media & sera
5.11.3.2 Reagents
5.11.4 Cell & tissue culture services
5.12 Cloning
5.12.1 Market for cloning, 2016 - 2027 (USD Million)
5.12.2 Kits, reagents, and consumables
5.12.3 Services
5.13 Other products & services
5.13.1 Market for other products & services, 2016 - 2027 (USD Million)
5.13.2 Antibodies
5.13.3 General supplies
5.13.4 Nucleic Acid Microarray
5.13.4.1 Instruments
5.13.4.2 Consumables
5.13.4.3 Services
5.13.5 Others
5.13.5.1 Market for others, 2016 - 2027 (USD Million)
5.13.5.2 Instruments
5.13.5.3 Consumables
5.13.5.4 Services
Chapter 6 End - use Movement Analysis
6.1 Market: End - use Movement Analysis
6.2 Government & Academic
6.2.1 Market for government & academic end use, 2016 - 2027 (USD Million)
6.3 Biopharmaceutical Company
6.3.1 Market for biopharmaceutical companies, 2016 - 2027 (USD Million)
6.4 Healthcare
6.4.1 Market for health care end use, 2016 - 2027 (USD Million)
6.5 Industrial Application
6.5.1 Market for industrial application, 2016 - 2027 (USD Million)
6.6 Others
6.6.1 Market for others end use, 2016 - 2027 (USD Million)
Chapter 7 Regional Movement Analysis
7.1 Market: Regional Movement Analysis
7.2 U.S.
7.2.1 Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
7.2.2 Market estimates and forecast, by product, 2016 - 2027 (USD Million)
7.2.3 Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
7.3 Canada
7.3.1 Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
7.3.2 Market estimates and forecast, by product, 2016 - 2027 (USD Million)
7.3.3 Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
Chapter 8 Company Profile
8.1 Company Profiles
8.1.1 Thermo Fisher Scientific, Inc.
8.1.1.1 Company Overview
8.1.1.1.1 Life Technologies Corp
8.1.1.2 Financial Performance
8.1.1.3 Product Benchmarking
8.1.1.4 Strategic Initiatives
8.1.2 F. Hoffmann - La Roche Ltd.
8.1.2.1 Company Overview
8.1.2.2 Financial Performance
8.1.2.3 Product Benchmarking
8.1.2.4 Strategic Initiatives
8.1.3 Illumina, Inc.
8.1.3.1 Company Overview
8.1.3.2 Financial Performance
8.1.3.3 Product Benchmarking
8.1.3.4 Strategic Initiatives
8.1.4 Agilent Technologies
8.1.4.1 Company Overview
8.1.4.2 Financial Performance
8.1.4.3 Product Benchmarking
8.1.4.4 Strategic Initiatives
8.1.5 Becton, Dickinson and Company (BD)
8.1.5.1 Company Overview
8.1.5.2 Financial Performance
8.1.5.3 Product Benchmarking
8.1.5.4 Strategic Initiatives
8.1.6 Bio - Rad Laboratories, Inc.
8.1.6.1 Company Overview
8.1.6.1.1 GnuBio
8.1.6.2 Financial Performance
8.1.6.3 Product Benchmarking
8.1.6.4 Strategic Initiatives
8.1.7 Danaher Corporation
8.1.7.1 Company Overview
8.1.7.1.1 Beckman Coulter, Inc.
8.1.7.1.2 Pall Corporation
8.1.7.2 Financial Performance
8.1.7.3 Product Benchmarking
8.1.7.4 Strategic Initiatives
8.1.8 General Electric Company
8.1.8.1 Company Overview
8.1.8.2 Financial Performance
8.1.8.3 Product Benchmarking
8.1.8.4 Strategic Initiatives
8.1.9 Merck KGaA
8.1.9.1 Company Overview
8.1.9.1.1 Sigma - Aldrich Co. LLC
8.1.9.1.2 Merck Millipore
8.1.9.2 Financial Performance
8.1.9.3 Product Benchmarking
8.1.9.4 Strategic Initiatives
8.1.10 QIAGEN
8.1.10.1 Company Overview
8.1.10.1.1 Ingenuity
8.1.10.1.2 CLC Bio
8.1.10.1.3 Exiqon
8.1.10.2 Financial Performance
8.1.10.3 Product Benchmarking
8.1.10.4 Strategic Initiatives
8.1.11 Corning Incorporated
8.1.11.1 Company Overview
8.1.11.2 Financial Performance
8.1.11.3 Product Benchmarking
8.1.11.4 Strategic Initiatives
8.1.12 Perkin Elmer, Inc.
8.1.12.1 Company Overview
8.1.12.2 Financial Performance
8.1.12.3 Product Benchmarking
8.1.12.4 Strategic Initiatives
8.1.13 Miltenyi Biotec
8.1.13.1 Company Overview
8.1.13.2 Financial Performance
8.1.13.3 Product Benchmarking
8.1.13.4 Strategic Initiatives
8.1.14 Bruker
8.1.14.1 Company Overview
8.1.14.2 Financial Performance
8.1.14.3 Product Benchmarking
8.1.14.4 Strategic Initiatives
8.1.15 Hitachi Koki Co., Ltd.
8.1.15.1 Company Overview
8.1.15.2 Financial Performance
8.1.15.3 Product Benchmarking
8.1.15.4 Strategic Initiatives
8.1.16 Shimadzu Corporation
8.1.16.1 Company Overview
8.1.16.2 Financial Performance
8.1.16.3 Product Benchmarking
8.1.16.4 Strategic Initiatives
8.1.17 Oxford Instruments
8.1.17.1 Company Overview
8.1.17.2 Financial Performance
8.1.17.3 Product Benchmarking
8.1.17.4 Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook